Stay updated on Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FSBphnh5W74cLXtu1dHrLloifixU.uncropped.jpg&w=3840&q=75)
Latest updates to the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page
- Check2 days agoChange DetectedThe website has updated the study details for Avutometinib (VS-6766) and Defactinib in recurrent low-grade serous ovarian cancer, including new dates and a revision update from v2.14.1 to v2.14.2, while removing previous entries with estimated dates.SummaryDifference2%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.1%
- Check24 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.3%
- Check53 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check60 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with the locations where the study is taking place.SummaryDifference3%
- Check75 days agoChange DetectedSeveral key URLs related to ovarian cancer and genetics have been removed, indicating a potential shift in focus or resource availability on the website.SummaryDifference5%
Stay in the know with updates to Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avutometinib Alone vs Combo in Low-Grade Serous Ovarian Cancer Clinical Trial page.